Monopar Therapeutics MNPR
NASDAQ MNPR
$73.75 +2.33 (+3.26%)
At close: Nov 9, 2026 · 4:00 PM EST

Monopar Therapeutics (MNPR) Total Non-Current Liabilities (2020)

Updated

Monopar Therapeutics (MNPR) posted Total Non-Current Liabilities of $54,628 for Q3 2020, down 27.2% from the prior quarter.

Analysis

Monopar Therapeutics (MNPR) Total Non-Current Liabilities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 102.65 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 117.60 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 36.05 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 96.04 Bn
10 Monopar Therapeutics 630.69 Mn 335.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 54,628.00
Jun 30, 2020 75,021.00
API Access

Monopar Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MNPR&period=max&api_key=YOUR_API_KEY